Safety Shot, Inc. (SHOT)
NASDAQ: SHOT · Real-Time Price · USD
0.875
-0.032 (-3.51%)
Nov 21, 2024, 4:00 PM EST - Market closed
Company Description
Safety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property.
The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content.
It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.
The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023.
Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Safety Shot, Inc.
| Country | United States |
| Founded | 2018 |
| IPO Date | Oct 30, 2020 |
| Industry | Beverages - Non-Alcoholic |
| Sector | Consumer Staples |
| Employees | 8 |
| CEO | Jarrett Boon |
Contact Details
Address: 1061 East Indiantown Road, Suite 110 Jupiter, Florida 33477 United States | |
| Phone | 561 244 7100 |
| Website | safetyshotofficial.com |
Stock Details
| Ticker Symbol | SHOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $7.50 |
| CIK Code | 0001760903 |
| ISIN Number | US48208F1057 |
| Employer ID | 83-2455880 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Jarrett A. Boon | Chief Executive Officer and Director |
| Jordan Schur | President and Director |
| Danielle De Rosa-Diaz | Chief Financial Officer |
| David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC | Chief Operating Officer |
| Anthony Pedicelli | Director of Marketing |
| Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
| Josh Wagner | Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 15, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 13, 2024 | 8-K | Current Report |
| Nov 6, 2024 | 8-K | Current Report |
| Nov 1, 2024 | EFFECT | Notice of Effectiveness |
| Nov 1, 2024 | 8-K | Current Report |
| Oct 29, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Oct 17, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Oct 11, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |